Designing the medicines of the future

At PharmEnable Therapeutics our mission is to develop innovative treatments for diseases with high unmet clinical need. With our scientist led, AI-enhanced approach, our aim is to create a drug discovery powerhouse with an asset-rich portfolio of next generation small molecule therapeutics.

Our pipeline

We are building an exciting pipeline of small molecule therapeutics against inaccessible targets in oncology and neurology. 

We focus on conditions where drug specificity is a particular challenge and where physical barriers pose a significant issue. 

PharmEnable Therapeutics pipeline

Accessing the inaccessible with small molecule therapeutics

We develop life changing medicines for cancer and neurological disease.

Partner with us

We’re open to discovery partnerships to develop medicines against inaccessible targets across disease areas.

We would be delighted to work with you.